Caricamento...
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis
Targeting the metastatic process is a critical pursuit in the treatment of malignant disease. There are currently no specific anti‐metastatic drugs approved for clinical use, despite metastasis being the leading cause of death for cancer patients. Targeting the Tie1 receptor was shown as a possible...
Salvato in:
| Pubblicato in: | EMBO Mol Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7278564/ https://ncbi.nlm.nih.gov/pubmed/32406209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012355 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|